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Master transcription factors Oct4, Sox2, and Nanog
bind enhancer elements and recruit Mediator to acti-
vate much of the gene expression program of plurip-
otent embryonic stem cells (ESCs). We report here
that the ESC master transcription factors form un-
usual enhancer domains at most genes that control
the pluripotent state. These domains, which we call
super-enhancers, consist of clusters of enhancers
that are densely occupied by the master regulators
and Mediator. Super-enhancers differ from typical
enhancers in size, transcription factor density and
content, ability to activate transcription, and sensi-
tivity to perturbation. Reduced levels of Oct4 or
Mediator cause preferential loss of expression of
super-enhancer-associated genes relative to other
genes, suggesting how changes in gene expression
programs might be accomplished during develop-
ment. In other more differentiated cells, super-
enhancers containing cell-type-specific master
transcription factors are also found at genes that
define cell identity. Super-enhancers thus play key
roles in the control of mammalian cell identity.
INTRODUCTION
Transcription factors typically regulate gene expression by bind-
ing cis-acting regulatory elements known as enhancers and by
recruiting coactivators and RNA polymerase II (RNA Pol II) to
target genes (Lelli et al., 2012; Ong and Corces, 2011). En-
hancers are segments of DNA that are generally a few hundred
base pairs in length and are typically occupied by multiple tran-
scription factors (Carey, 1998; Levine and Tjian, 2003; Panne,
2008; Spitz and Furlong, 2012).
Much of the transcriptional control of mammalian develop-
ment is due to the diverse activity of transcription-factor-bound
enhancers that control cell-type-specific patterns of geneexpression (Bulger and Groudine, 2011; Hawrylycz et al., 2012;
Maston et al., 2006). Between 400,000 and 1.4 million putative
enhancers have been identified in the mammalian genome by
using a variety of high-throughput techniques that detect fea-
tures of enhancers such as specific histone modifications (Dun-
ham et al., 2012; Thurman et al., 2012). The number of enhancers
that are active in any one cell type has been estimated to be in
the tens of thousands, and enhancer activity is largely cell-type
specific (Dunham et al., 2012; Heintzman et al., 2009; Shen
et al., 2012; Visel et al., 2009; Yip et al., 2012).
In embryonic stem cells (ESCs), control of the gene expression
program that establishes and maintains ESC state is dependent
on a remarkably small number ofmaster transcription factors (Ng
and Surani, 2011; Orkin and Hochedlinger, 2011; Young, 2011).
These transcription factors, which include Oct4, Sox2, and
Nanog (OSN), bind to enhancers together with the Mediator
coactivator complex (Kagey et al., 2010). The Mediator complex
facilitates the ability of enhancer-bound transcription factors to
recruit RNA Pol II to the promoters of target genes (Borggrefe
and Yue, 2011; Conaway and Conaway, 2011; Kornberg, 2005;
Malik and Roeder, 2010) and is essential for maintenance of
ESC state and embryonic development (Ito et al., 2000; Kagey
et al., 2010; Risley et al., 2010).
ESCs are highly sensitive to reduced levels of Mediator.
Indeed, reductions in the levels of many subunits of Mediator
cause the same rapid loss of ESC-specific gene expression as
loss of Oct4 and other master transcription factors (Kagey
et al., 2010). It is unclear why reduced levels of Mediator, a gen-
eral coactivator, can phenocopy the effects of reduced levels of
Oct4 in ESCs.
Interest in further understanding the importance of Mediator in
ESCs led us to further investigate enhancers bound by the mas-
ter transcription factors and Mediator in these cells. We found
that much of enhancer-associated Mediator occupies excep-
tionally large enhancer domains and that these domains are
associated with genes that play prominent roles in ESC biology.
These large domains, or super-enhancers, were found to contain
high levels of the key ESC transcription factors Oct4, Sox2,
Nanog, Klf4, and Esrrb to stimulate higher transcriptional activity
than typical enhancers and to be exceptionally sensitive toCell 153, 307–319, April 11, 2013 ª2013 Elsevier Inc. 307
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reduced levels of Mediator. Super-enhancers were found in a
wide variety of differentiated cell types, again associated with
key cell-type-specific genes known to play prominent roles in
control of their gene expression program. These results indicate
that super-enhancers drive genes that are essential for cell iden-
tity in many mammalian cell types.
RESULTS
Large Genomic Domains Occupied by Master
Transcription Factors and Mediator in ESCs
Previous studies have shown that co-occupancy of ESC
genomic sites by the Oct4, Sox2, and Nanog transcription fac-
tors is highly predictive of enhancer activity (Chen et al., 2008)
and that Mediator is typically associated with these sites (Kagey
et al., 2010). We generated high-quality chromatin immunopre-
cipitation (ChIP)-seq data sets for Oct4, Sox2, and Nanog
(OSN) inmurine ESCs and identified 8,794 sites that are co-occu-
pied by these three transcription factors to annotate enhancers in
ESCs (Table S1 and Data S1 available online). Inspection of en-
hancers at several genes that have prominent roles in ESC
biology revealed an unusual feature: a large domain containing
clusters of constituent enhancers (Figure 1). Although the vast
majority of enhancers spanned DNA segments of a few hundred
base pairs (Figure 1A), some portions of the genome contained
clusters of enhancers spanning as much as 50 kb (Figure 1B).
We found that ESC enhancers can be divided into two classes
based on Mediator levels—one class comprised the vast major-
ity of enhancers, and the other encompassed 231 large enhancer
domains (Figure 1C). Approximately 40% of the Mediator signal
associated with enhancers was found in these 231 enhancer
domains. The key features of the 231 domains containing highFigure 1. Enhancers and Super-Enhancers in ESCs
(A and B) ChIP-seq binding profiles (reads per million per base pair) for the ESC tr
(Med1) at the Gck and miR-290-295 loci in ESCs. Gene models are depicted bel
binding profiles.
(C) Distribution of Mediator ChIP-seq signal (total reads) across the 8,794 ESC e
regions, with a subset of enhancers (the 231 super-enhancers) containing excep
(D) Metagenes of Mediator ChIP-seq density (reads per million per base pair) acr
centered on the enhancer region (703 base pairs for typical enhancers and 8.7 kb
fold difference for enhancer features Mediator, H3K27ac, H3K4me1, and DNase
below the metagenes. Fold difference at enhancers refers to the mean ChIP-seq
typical enhancers. Fold difference at enhancer constituents refers to the mean Ch
divided by the mean ChIP-seq density at typical enhancer constituents. See also
(E) Distribution of Mediator, H3K27ac, H3K4me1, DNaseI hypersensitivity, and O
For each enhancer feature, the plot was normalized by dividing the ChIP-seq sign
the x axis are ranked for each enhancer feature independently (i.e., the exact enh
are adjusted so that the differences in the distribution of each of the enhancer fe
(F) ChIP-seq binding profiles for Oct4, Sox2, Nanog, Klf4, and Esrrb at the Gck a
(G) Metagenes of Oct4, Sox2, Nanog, Klf4, and Esrrb ChIP-seq density across th
enhancer regions. Each metagene is centered on a constituent enhancer with 2
(H) Box plots of Oct4, Sox2, Nanog, Klf4, and Esrrb ChIP-seq density at constitue
Box plot whiskers extend to 1.53 the interquartile range. p values (Oct4 = 0.012
using a two-tailed t test.
(I) Table depicting transcription factor binding motifs enriched at constituent en
associated p values. CTCF and c-Myc are not enriched.
(J) Left: box plot depicting the number of Oct4, Sox2, or Nanog bindingmotifs at co
super-enhancers. Box plot whiskers extend to 1.53 the interquartile range. Righ
enhancers within typical enhancers and constituent enhancers within super-enha
calculated using a two-tailed t test.
See also Figure S1, Tables S1, S2, and S8, and Data S1.levels of Mediator, which we call super-enhancers, are that (1)
they span DNA regions whose median length is an order of
magnitude larger than the typical enhancer and that (2) they
have levels of Mediator that are at least an order of magnitude
greater than those at the typical enhancer (Figure 1D).
Further characterization of the ESC super-enhancer regions
revealed that they contain many features of typical enhancers
but at a considerably larger scale (Figures 1D and S1A). Previous
studies have shown that nucleosomeswith the histonemodifica-
tions H3K27ac and H3K4me1 are enriched at active enhancers
(Creyghton et al., 2010; Rada-Iglesias et al., 2011). Based on
ChIP-seq data, the levels of these histone modifications at the
super-enhancers exceed those at the typical enhancers by at
least an order of magnitude (Figure 1D). These high levels of
histone modifications are due both to the size of the domain
and to the density of occupancy at constituent enhancers
(Figure 1D). Similar results were obtained for DNase I hypersen-
sitivity (Figures 1D and S1A), another feature of enhancers (Dun-
ham et al., 2012). We compared the relative ability of ChIP-seq
data for OSN, Mediator, H3K27ac, H3K4me1, as well as DNaseI
hypersensitivity data to distinguish super-enhancers from
typical enhancers (Extended Experimental Procedures and Fig-
ure S1B). We found that Mediator performed optimally, although
each of these enhancer features could be used to some degree
to distinguish super-enhancers from typical enhancers (Figures
1E and S1B).
To investigate whether the super-enhancers have features
that might further distinguish them from typical enhancers, we
examined ChIP-seq data for 18 different transcription factors,
histone modifications, and chromatin regulators, as well as
DNaseI hypersensitivity (Table S2). The most striking difference
was in the occupancy of transcription factors Klf4 and Esrrbanscription factors Oct4, Sox2, and Nanog (OSN) and the Mediator coactivator
ow the binding profiles. Enhancer bars and scale bars are depicted above the
nhancers. Mediator occupancy is not evenly distributed across the enhancer
tionally high amounts of Mediator.
oss the 8,563 typical enhancers and the 231 super-enhancers. Metagenes are
for super-enhancers), with 3 kb surrounding each enhancer region. ChIP-seq
I hypersensitivity at super-enhancers versus typical enhancers are displayed
signal (total reads) at super-enhancers divided by the mean ChIP-seq signal at
IP-seq density (reads per million per base pair) at super-enhancer constituents
Figure S1A and Data S1.
SN normalized ChIP-seq signal across a subset of the 8,794 ESC enhancers.
al at each ESC enhancer by the maximum ChIP-seq signal. The enhancers on
ancer at position 8,000 is different for each enhancer feature). The x and y axes
atures can be visualized. See also Figure S1B.
nd miR-290-295 loci in ESCs.
e constituent enhancers within the 8,563 typical enhancers and the 231 super-
kb surrounding the constituent enhancer region.
nt enhancers within the 8,563 typical enhancers and the 231 super-enhancers.
, Nanog = 104, Sox2 = 0.11, Klf4 = 1034, and Esrrb = 1025) were calculated
hancers within super-enhancer regions relative to genomic background and
nstituent enhancers within typical enhancers and constituent enhancers within
t: box plot depicting the number of Klf4 or Esrrb binding motifs at constituent
ncer regions. p values (Oct4/Sox2/Nanog = 0.36 and Klf4/Esrrb = 1045) were
Cell 153, 307–319, April 11, 2013 ª2013 Elsevier Inc. 309
(Figures 1F–1H). Although the levels of Oct4, Sox2, and Nanog
were similar in constituent enhancers within typical enhancers
and super-enhancers (p = 0.012, 104, and 0.11, respectively),
the levels of Klf4 and Esrrb showed considerably higher occu-
pancy at the constituent enhancers of super-enhancer domains
(p < 1034 and 1025, respectively) (Figures 1G and 1H). Thus,
super-enhancers are not simply clusters of typical enhancers
but are particularly enriched in Klf4 and Esrrb, which have previ-
ously been shown to play important roles in the ESC gene
expression program and in reprogramming of somatic cells to
induced pluripotent stem (iPS) cells (Feng et al., 2009; Festuccia
et al., 2012; Jiang et al., 2008; Martello et al., 2012; Percharde
et al., 2012; Takahashi and Yamanaka, 2006).
To gain additional insights into the mechanisms involved in
super-enhancer formation, we studied the frequency of known
transcription factor binding motifs in these and other regions of
the genome. We found that constituent enhancers within
super-enhancer regions were significantly enriched for
sequence motifs bound by Oct4, Sox2, Nanog, Klf4, and Esrrb,
but not for motifs bound by other transcription factors expressed
in ESCs such as CTCF and c-Myc (Figure 1I). The sequence
motifs for Oct4, Sox2, and Nanog showed similar levels of
enrichment at typical enhancers and constituent enhancers
within super-enhancer domains, but motifs for Klf4 and Esrrb
were significantly enriched in the constituent enhancers within
super-enhancers (p < 1045) (Figure 1J). These data indicate
that ESC super-enhancers are large clusters of enhancers that
can be distinguished from typical enhancers by the presence
of the transcription factors Klf4 and Esrrb and exceptional levels
of Mediator and indicate that these domains are formed as a
consequence of binding of specific master transcription factors
to dense clusters of their binding site sequences.
Super-Enhancers Are Associated with Key ESC
Identity Genes
Enhancers tend to loop to and associate with adjacent genes in
order to activate their transcription (Ong andCorces, 2011).Most
of these interactions occur within a distance of 50 kb of the
enhancer, although many can occur at greater distances up to
several megabases (Sanyal et al., 2012). Previous studies have
utilized various methods to assign enhancers to their target
genes, including proximity, enhancer-promoter unit assignments
(EPUs), and genome-wide interactions discovered by chromo-
some conformation capture techniques (Dixon et al., 2012;
Shen et al., 2012; Whyte et al., 2012). We initially used proximity
to assign 231 super-enhancers to 210 genes (Table S1) because
the super-enhancers tend to overlap the genes with which they
were associated. These super-enhancer proximity assignments
were highly consistent (95% agreement) with EPU assignments
(Table S3). In addition, 93% of the super-enhancer-promoter
pairs identified by proximity occur within the same topological
domains defined by Hi-C (Figure 2A and Table S3). Furthermore,
for three of these genes (Oct4, Nanog, and Lefty1), interactions
between portions of the super-enhancer and the target promoter
were previously demonstrated using chromatin conformation
capture (3C) (Kagey et al., 2010).
The set of super-enhancer-associated genes contained nearly
all genes that have been implicated in control of ESC identity310 Cell 153, 307–319, April 11, 2013 ª2013 Elsevier Inc.(Table S1). They included genes encoding the master ESC tran-
scription factors Oct4, Sox2, and Nanog (Figure 2B and Table
S1). They also included genes encoding most other transcription
factors implicated in control of ESC identity, as well as genes
encoding DNA-modifying enzymes and MicroRNAs (miRNAs)
that feature prominently in the control of the ESC gene expres-
sion program (Figure 2C). For example, Klf4 and Esrrb play
important roles in ESC biology and can facilitate reprogramming
(Feng et al., 2009; Festuccia et al., 2012; Jiang et al., 2008; Mar-
tello et al., 2012; Percharde et al., 2012; Takahashi and Yama-
naka, 2006). The products of the Tet genes are associated with
most active promoters and are responsible for global 5-hydrox-
ymethylation of DNA in ESCs (Wu et al., 2011; Yu et al., 2012a).
ThemiR-290-295 locus produces the most abundant miRNAs in
ESCs (Calabrese et al., 2007) and is essential for embryonic sur-
vival (Medeiros et al., 2011).
Previous studies have identified genes encoding a broad
range of transcription factors, coactivators, and chromatin
regulators that are necessary for maintenance of the ESC state
(Ding et al., 2009; Fazzio et al., 2008; Hu et al., 2009; Kagey
et al., 2010). To further investigate the extent to which super-
enhancer-associated genes are involved in control of ESC state,
we compared the set of super-enhancer-associated genes to
the genes in a short hairpin RNA (shRNA) knockdown screen
involving 2,000 regulators, which included most transcription
factors and chromatin regulators encoded in the mouse genome
(Kagey et al., 2010). We found that the majority of genes encod-
ing transcription factors, coactivators, and chromatin regulators
whose knockdown most profoundly caused loss of ESC state
are associated with super-enhancers (p < 102) (Figure 2D).
This further supports the notion that super-enhancer-associated
genes encode many regulators that are key to establishing and
maintaining ESC state.
Genes encoding transcription factors were the predominant
class of super-enhancer-associated genes based on analysis
of gene ontology functional categories (Figure 2E). In contrast,
super-enhancers were not found to be associated with house-
keeping genes (Figure S2). The ESCmaster transcription factors
Oct4, Sox2, and Nanog have previously been shown to form an
interconnected autoregulatory loop in which all three factors
bind as a group to the promoters of each of their own genes
and form the core regulatory circuitry of ESCs (Boyer et al.,
2005; Loh et al., 2006). The discovery of Klf4 and Esrrb at su-
per-enhancers and evidence that Klf4 and Esrrb play important
roles in the ESC gene expression program and in reprogramming
of somatic cells to iPS cells (Feng et al., 2009; Takahashi and Ya-
manaka, 2006) suggest that this autoregulatory loop should be
expanded to include Klf4 and Esrrb (Figure 2F).
Functional Attributes of Super-Enhancers
Super-enhancer-associated genes are generally expressed at
higher levels than genes associated with typical enhancers (p <
105) (Figures 3A and S3A and Table S4), suggesting that
super-enhancers drive high-level expression of their target
genes. To test whether super-enhancers confer stronger en-
hancer activity than typical ESC enhancers, we cloned DNA frag-
ments from these elements into luciferase reporter constructs
that were subsequently transfected into ESCs. Constituent
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Figure 2. Super-Enhancers Are Associated with Key ESC Pluripo-
tency Genes
(A) ChIP-seq binding profiles for OSN and Med1 at the Klf4 locus in ESCs.
Previously described Hi-C interaction frequency (normalized interaction
counts) and genomic coordinates comprising a portion of a topological
domain (Dixon et al., 2012) are indicated above the binding profiles.
(B) ChIP-seq binding profiles for OSN and Med1 at the Oct4 and Sox2 loci in
ESCs. Gene models are depicted below the binding profiles.
(C) List of selected genes associated with super-enhancers and playing
prominent roles in ESC biology.
(D) Super-enhancers are associated with genes encoding transcription fac-
tors, coactivators, and chromatin regulators important for maintenance of ESC
state. The gene set enrichment analysis (GSEA) of super-enhancer-associated
genes reveals that these genes encode regulators whose shRNA knockdown
most impact Oct4 expression and ESC state. Knockdown of genes important
for ESC identity causes Oct4 loss, which is reflected by a negative Z score. p
value (102) was calculated as part of the GSEA analysis.
(E) Gene ontology (GO) functional categories for super-enhancer-associated
genes. Genes encoding factors important for DNA synthesis, protein synthe-
sis, and metabolism were not enriched. See also Figure S2.
(F) Schematic diagram of a small portion of the ESC core regulatory circuitry.
Genes encoding the master transcription factors are themselves driven
by super-enhancers. These master factors form an interconnected feedback
loop and regulate their own expression, as well as the expression of other
transcription factors and noncoding RNAs that play prominent roles in ESC
biology.
See also Figure S2 and Table S3.enhancer segments within the super-enhancers, defined as a
600–1,400 base pair region with a single peak of Oct4/Sox2/
Nanog occupancy, generated higher luciferase activity relative
to single peaks from typical enhancers (3.8-fold higher; p =
0.02) (Figure 3B). These results are consistent with the idea
that super-enhancers and their components help drive high
levels of transcription of the key genes that control ESC identity.
To obtain clues to the factors that contribute to the higher
activity of individual enhancer elements within super-enhancers,
we determined whether the levels of particular transcription
factors at the enhancer elements, based on ChIP-seq data for
the genomic locus, correlated with the levels of luciferase activity
in the reporter assays. The presence of Klf4 and Esrrb was corre-
latedwith high levels of luciferase activity (Figure S3B). Thus, Klf4
and Esrrb, which are especially enriched in super-enhancers
(Figure 1G), may contribute to the superior activity of the
enhancer elements from super-enhancers in these reporter
assays.
We next investigated whether the functional attributes of
super-enhancersmight account for the observation that reduced
levels of either Oct4 or Mediator have very similar effects on the
ESC gene expression program and cause the same rapid loss of
ESC state (Kagey et al., 2010). Enhancers typically function
through cooperative and synergistic interactions between multi-
ple transcription factors and coactivators (Carey, 1998; Carey
et al., 1990; Giese et al., 1995; Kim and Maniatis, 1997; Thanos
and Maniatis, 1995). The transcriptional output of enhancers
with large numbers of transcription factor binding sites can be
more sensitive to changes in transcription factor concentration
than those with smaller numbers of binding sites (Giniger and
Ptashne, 1988; Griggs and Johnston, 1991). We therefore hy-
pothesized that super-enhancer-associated genes may be
more sensitive to perturbations in the levels of enhancer-bindingCell 153, 307–319, April 11, 2013 ª2013 Elsevier Inc. 311
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Figure 3. Super-Enhancers Confer High Transcriptional Activity and
Sensitivity to Perturbation
(A) Box plots of expression (reads per kilobase of exon per million mapped
reads, RPKM) from typical-enhancer-, super-enhancer-, and all enhancer-
associated genes, as well as the top 1,000 highest expressed housekeeping
genes. The number of genes belonging to each category for which we have
expression data is denoted. Box plot whiskers extend to 1.53 the interquartile
range. p value (105) was calculated using a two-tailed t test. See also Fig-
ure S3A and Table S4.
(B) Top: ChIP-seq binding profiles for OSN and Med1 at the Sgk1 typical
enhancer and Esrrb super-enhancer loci. Gray bars with dashed borders
indicates cloned regions. Bottom: plot of luciferase activity 24 hr post-
transfection, normalized to a transfected control plasmid. Enhancers neigh-
boring selected genes were cloned into reporter plasmids containing the
Luciferase gene regulated by the Oct4 promoter and were subsequently
transfected into ESCs. p value (0.02) was calculated using a two-tailed t test.
See also Figure S3B.
(C) Top: schematic diagram of ESCs transduced with shRNAs against Oct4.
Bottom: box plots of fold change expression in differentiating ESCs (3, 4, and
5 days after transduction) relative to control ESCs transduced with shRNAs
against GFP. Box plot whiskers extend to 1.53 the interquartile range. p values
(day 3 = 105, day 4 = 108, and day 5 = 1010) were calculated using a two-
tailed t test. See also Figure S3C.
(D) Top: schematic diagram of ESCs transduced with shRNAs against
the Mediator subunit Med12. Bottom: box plots of fold change expression
in Mediator-depleted ESCs (3, 4, and 5 days after transduction) relative to
control ESCs. Box plot whiskers extend to 1.53 the interquartile range.
p values (day 3 = 1011, day 4 = 1011, and day 5 = 1013) were calculated
using a two-tailed t test.
See also Figure S3 and Tables S4 and S7.
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carried out two tests of this model.
In ESCs, reducing the levels of Oct4 leads to loss of
ESC-specific gene expression and differentiation. If super-
enhancer-associated genes are more sensitive to loss of master
transcription factors than other genes, then a reduction in Oct4
levels should cause a preferential loss of super-enhancer-
associated gene expression. To test this idea, we reduced the
levels of Oct4 transcription using shRNAs, which leads to activa-
tion of the trophectoderm master transcription factor Cdx2 and
cellular differentiation (Figure 3C) (Niwa et al., 2005; Strumpf
et al., 2005). Oct4 depletion results in changes in cellular
morphology consistent with ESC differentiation by 5 days (Fig-
ure S3C). We analyzed gene expression 3, 4, and 5 days after
Oct4 depletion and observed that super-enhancer-associated
genes suffered an earlier and more profound reduction in the
levels of transcripts than those associated with typical en-
hancers (p < 105, 108, and 1010, respectively) (Figure 3C).
These results indicate that the transcriptional output of ESC
super-enhancer-associated genes is rapidly and preferentially
reduced during differentiation.
If super-enhancer-associated genes aremore sensitive to loss
of coactivators than other genes, then a reduction in levels of
Mediator subunits should preferentially affect expression of
super-enhancer-associated genes. When the levels of Mediator
were reduced using shRNAs in ESCs, the most pronounced
effects on gene expression were observed at super-enhancer-
associated genes (p < 1011, 1011, and 1013, respectively)
(Figure 3D). In summary, these results indicate that reducing
the levels of Oct4 and Mediator lead to more profound effects
on expression of super-enhancer-associated genes than on
other active genes with typical enhancers. These results may
thus account for the observation that loss of Oct4 and loss of
Mediator subunits have similar effects on ESC state (Kagey
et al., 2010).
Super-Enhancers in B Cells
We investigated whether the super-enhancers found in ESCs
had similar counterparts in differentiated cells. We annotated
13,814 enhancers using ChIP-seq data for the master transcrip-
tion factor PU.1 in murine progenitor B (pro-B) cells (Table S5)
(DeKoter and Singh, 2000; Nutt and Kee, 2007). Previous studies
have shown that occupancy of pro-B genomic sites by PU.1 is
predictive of enhancer activity (Abujarour et al., 2010; Wlodarski
et al., 2007). We found that genome-wide occupancy of the
master transcription factor PU.1 and Mediator were highly
correlated (Figures 4A and S4). When the levels of Mediator
were plotted against enhancers ranked by ChIP-seq signal,
the enhancers in these cells fell into two classes, as was
observed for ESCs (Figure 4B). The pro-B cells had 395 large
domains that shared key characteristics with the super-en-
hancers found in ESCs—they spanned DNA domains whose
median length is an order of magnitude larger than the typical
enhancer, and they had levels of Mediator that are at least an
order of magnitude greater than those at the typical enhancer
(Figure 4C). Nearly 40% of all Mediator signal observed at en-
hancers was associated with the super-enhancer domains in
pro-B cells.
We studied the frequency of DNA sequences bound by pro-B
transcription factors in super-enhancers and in other regions of
the genome. Constituent enhancers within super-enhancer re-
gions were significantly enriched for clusters of sequence motifs
bound by PU.1, as well as for a set of other transcription factors
that have been implicated in control of B cells (Figures 4D and
4E). The transcription factors with sequence motif enrichment
in the super-enhancer domains included Ebf1, E2A, and
Foxo1, which have previously been shown to be important for
control of B cells (Lin et al., 2010). The sequence motif for E2A
was significantly more enriched at super-enhancer constituents
relative to typical enhancer constituents (p < 1022) (Figure 4E).
E2A is essential for pro-B cell development during B cell lympho-
poiesis (Kwon et al., 2008). These findings are consistent with
those obtained for ESCs, where DNA sequence motifs for the
master transcription factors were enriched in closely spaced
clusters.
We next identified genes associated with super-enhancers in
pro-B cells and found that many of these are prominent regula-
tors of B cell identity (Figure 4F). For example, super-
enhancer-associated genes in pro-B cells included Foxo1 and
Inpp5d. In common lymphoid progenitors, Foxo1 acts in concert
with Ebf1 to specify B cell fate as part of a positive feedback loop
(Mansson et al., 2012), whereas the lipid-metabolizing enzyme
encoded by Inpp5d, SHIP1, dephosphorylates proteins to
regulate the B cell antigen receptor (BCR) signaling response
(Alinikula et al., 2010). As in ESCs, the genes associated with
super-enhancers in pro-B cells were expressed at higher levels
than those associated with typical enhancers (p < 106) (Fig-
ure 4G and Table S5).Super-Enhancers Are Cell-Type Specific and Mark Key
Cell Identity Genes
To further investigate whether super-enhancers are a general
feature of mammalian cells, we extended the study of these ele-
ments to a set of other cell types where the key transcription fac-
tors that control cell state are well defined (Figure 5). We found
that the master transcription factors of mouse myotubes
(MyoD), T helper (Th) cells (T-bet), and macrophages (C/EBPa)
also bind large domains with clusters of enhancers (Figures
S5A and S5B), and these large domains are associated with
genes that feature predominantly in the biology of these cells
(Figures 5A and S5C and Table S6). In myotubes, for example,
a super-enhancer is associated with the gene encoding MyoD,
which is a master regulator of skeletal muscle and is the first fac-
tor shown to reprogram fibroblasts into muscle cells (Tapscott,
2005; Weintraub et al., 1989). In Th cells, a super-enhancer is
associated with the gene Tcf7 that encodes T cell factor 1
(Tcf-1), which is critical for the production of T cells during hema-
topoiesis (Staal and Sen, 2008; Xue and Zhao, 2012; Yu et al.,
2012b). In macrophages, a super-enhancer is associated with
the gene encoding the extracellular matrix glycoprotein Thbs-
1, which is involved in scavenger recognition of apoptotic cells
by macrophages (Savill et al., 1992). These results support the
notion that the key transcription factors controlling cell state
bind to clusters of enhancers that are associated with specific
genes that are key to cell identity.
The set of enhancers that are bound by transcription factors
and control transcription in any one cell type can promote
expression of both cell-type-specific genes and genes that are
active in multiple cell types (Dunham et al., 2012; Shen et al.,
2012; Yip et al., 2012). The super-enhancer elements identified
in ESCs, pro-B cells, myotubes, Th cells, and macrophages
spanned domains that were almost entirely cell-type specific
(Figures 5A and S5D), and the genes associated with these
elements were highly cell-type specific relative to typical
enhancer-associated genes (Figures 5B and 5C). These results
are consistent with the idea that super-enhancers are formed
by the binding of key transcription factors to clusters of binding
sites that are associated with genes controlling unique cellular
identities.
If super-enhancers generally form at genes whose functions
are associated with cell identity, we might expect super-
enhancer-associated genes to be defining of cell type. When
gene ontology analysis was conducted using the set of genes
associated with super-enhancers in each cell type, we found
that the top ten most significant biological process terms
obtained for each cell type were remarkably descriptive of
each cell’s specific function (Figure 5D). This result suggests
that super-enhancer-associated genes may be valuable bio-
markers for cell identity.
DISCUSSION
We have identified exceptionally large enhancer domains that
are occupied by master transcription factors and are associated
with genes encoding key regulators of cell identity. In ESCs,
these super-enhancers consist of clusters of enhancer elements
that are formed by the binding of key transcription factors andCell 153, 307–319, April 11, 2013 ª2013 Elsevier Inc. 313
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Figure 4. Super-Enhancers in Pro-B Cells
(A) ChIP-seq binding profiles for PU.1 and Med1 at the Foxo1 locus in pro-B cells.
(B) Distribution of Mediator ChIP-seq density across the 13,814 pro-B enhancers, with a subset of enhancers (the 395 super-enhancers) containing exceptionally
high amounts of Mediator. See also Figure S4.
(C) Metagenes of Mediator density across the typical and super-enhancers in pro-B cells. Metagenes are centered on the enhancer region (422 base pairs for
typical enhancers and 15.4 kb for super-enhancers), with 3 kb surrounding each enhancer region. ChIP-seq fold difference for Mediator at super-enhancers
versus typical enhancers is displayed below the metagenes.
(D) Table depicting transcription factor binding motifs enriched at constituent enhancers within super-enhancer regions relative to genomic background and
associated p values. CTCF and Zfx are not enriched.
(E) Left: box plot depicting the number of PU.1, Ebf1, or Foxo1 bindingmotifs at constituent enhancers within typical enhancers and constituent enhancers within
super-enhancers. Right: box plot depicting the number of E2A binding motifs at constituent enhancers within typical enhancers and constituent enhancers within
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(legend continued on next page)
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the Mediator coactivator complex. The ESC super-enhancers
differ from typical enhancers in size, transcription factor density
and content, ability to activate transcription, and sensitivity to
perturbation. Super-enhancers are found in a wide variety of
other cell types, where they are associated with key cell-type-
specific genes known to play prominent roles in their biology. Su-
per-enhancers are also observed in cancer cells, where they are
associated with critical oncogenic drivers (Love´n et al., 2013 [this
issue of Cell]). These results implicate super-enhancers in the
control of mammalian cell identity and disease.
Super-enhancer formation appears to occur as a conse-
quence of binding of large amounts of master transcription
factors to clusters of DNA sequences that are relatively abundant
across these large domains. The ESC transcription factors Oct4,
Sox2, Nanog, Klf4, and Esrrb have DNA binding motifs that are
enriched in super-enhancer domains. Super-enhancers are not
simply clusters of typical enhancers but are particularly enriched
in Klf4 and Esrrb, which have previously been shown to play
important roles in the ESC gene expression program and in
reprogramming of somatic cells to iPS cells (Feng et al., 2009;
Festuccia et al., 2012; Jiang et al., 2008; Martello et al., 2012;
Percharde et al., 2012; Takahashi and Yamanaka, 2006).
Furthermore, super-enhancer-associated genes are highly sen-
sitive to reduced levels of enhancer-bound factors and cofac-
tors. We speculate that the signals that naturally cause ESCs
to differentiate may exploit this sensitivity of super-enhancer-
associated genes to facilitate transitions to new gene expression
programs.
Remarkably, the genes encoding the ESC master transcrip-
tion factors are themselves driven by super-enhancers, forming
a feedback loop where the key transcription factors regulate
their own expression (Figure 2F). Earlier studies identified a
portion of this interconnected autoregulatory loop consisting
of the genes encoding Oct4, Sox2, and Nanog but were un-
aware of the unusual enhancer structure associated with genes
in this regulatory loop (Boyer et al., 2005; Loh et al., 2006). The
formation of super-enhancers at these genes is also of interest
because it suggests that super-enhancers may generally identify
genes that are important for control of cell identity and, in some
cases, are capable of reprogramming cell fate. Indeed, we found
evidence for super-enhancers associated with genes that con-
trol cell identity in a wide range of cell types, and some of these
genes do encode factors that have been demonstrated to repro-
gram cell fate.
We found that super-enhancers can be identified by searching
for clusters of binding sites for enhancer-binding transcription
factors, and they can be distinguished from typical enhancers
by occupancy of cofactors or enhancer-associated surrogate
marks such as histone H3K27ac or DNaseI hypersensitivity. Pre-
vious studies have noted that many different ESC transcription
factors can bind to sites called multiple transcription-factor-
binding loci (Chen et al., 2008; Kim et al., 2008), but these loci(F) List of selected genes associated with super-enhancers and playing promine
(G) Box plots of expression from typical-enhancer-, super-enhancer-, and all
to each category for which we have expression data is denoted. Box plot whiske
a two-tailed t test.
See also Figure S4 and Table S5.differ from super-enhancers and are associated with different
genes. Other studies have also identified large genomic do-
mains involved in gene control but have not noted that genes
encoding the key regulators of cell state are generally driven
by super-enhancers. For example, large control regions with
clusters of transcription factor binding sites or DNaseI hypersen-
sitivity sites have been described for the IgH enhancer (20 kb),
the Th cell receptor (11.5 kb), the b-globin enhancer (16 kb),
and others (Diaz et al., 1994; Forrester et al., 1990; Grosveld
et al., 1987; Madisen and Groudine, 1994; Michaelson et al.,
1995; Orkin, 1990). It is possible that previous studies did not
note large domains of enhancer activity associated with key
cell identity genes because most existing algorithms typically
seek evidence for factor binding or DNaseI hypersensitivity
within small regions of the genome. There are, however, algo-
rithms that are designed to identify large domains (Ernst and
Kellis, 2010; Filion et al., 2010; Hon et al., 2008; Thurman
et al., 2012), and the algorithm we describe here should be use-
ful for further discovery of super-enhancers and other large
domains.
The presence of super-enhancers at key cell identity genes
provides novel insights into transcriptional control of mammalian
cells. The evidence described here indicates that mammalian
genomes have evolved clusters of DNA sequences near genes
encoding key drivers of cell state. These clusters are bound by
a combination of key transcription factors to form cell-type-spe-
cific super-enhancers and, in this fashion, control the gene
expression programs associated with specific cell identities.
The concept of super-enhancers may facilitate mapping of the
regulatory circuitry of many different cell types comprising mam-
mals. Discovering how thousands of transcription factors coop-
erate to control gene expression programs in the vast number of
cells in vertebrates is a highly complex undertaking. If only a few
hundred super-enhancers dominate control of the key genes
that establish and maintain cellular identity, however, it may be
possible to create basic models that describe the key features
of transcriptional control of cell state.
EXPERIMENTAL PROCEDURES
Cell Culture
V6.5 murine ESCs were grown on irradiated murine embryonic fibroblasts
(MEFs). Cells were grown under standard ESC conditions as described previ-
ously (Whyte et al., 2012). Cells were grown on 0.2% gelatinized (Sigma,
G1890) tissue culture plates in ESC media; DMEM-KO (Invitrogen, 10829-
018) supplemented with 15% fetal bovine serum (Hyclone, characterized
SH3007103), 1,000 U/ml LIF (ESGRO, ESG1106), 100 mM nonessential amino
acids (Invitrogen, 11140-050), 2 mM L-glutamine (Invitrogen, 25030-081),
100 U/ml penicillin, 100 mg/ml streptomycin (Invitrogen, 15140-122), and
8 nl/ml of 2-mercaptoethanol (Sigma, M7522).
ChIP-Seq
ChIP was carried out as described previously (Boyer et al., 2005). Additional
details are provided in the Extended Experimental Procedures. ChIP-seq ofnt roles in B cell biology.
enhancer-associated genes in pro-B cells. The number of genes belonging
rs extend to 1.53 the interquartile range. p value (106) was calculated using
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Figure 5. Super-Enhancers Are Generally Associated with Key Cell Identity Genes
(A) ChIP-seq binding profiles for master transcription factors (OSN in ESCs; PU.1 in pro-B cells; MyoD in myotubes; T-bet in Th cells; C/EBPa in macrophages) at
the Esrrb, Inpp5d, Myod1, Tcf7, and Thbs-1 loci. See also Figures S5A and S5B.
(B) Venn diagrams of typical-enhancer-associated and super-enhancer-associated genes in ESCs (blue border), pro-B cells (green border), and myotubes
(orange border).
(legend continued on next page)
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Mediator was generated using a Med1 antibody (Bethyl Labs A300-793A, Lot
A300-793A-2).
Illumina Sequencing and Library Generation
Purified ChIP DNA was used to prepare Illumina multiplexed sequencing
libraries. Libraries for Illumina sequencing were prepared following the Illumina
TruSeq DNA Sample Preparation v2 kit protocol with exceptions described in
the Extended Experimental Procedures.
Luciferase Expression Constructs
AminimalOct4 promoter was amplified frommouse genomic DNA and cloned
into the XhoI and HindIII sites of the pGL3 basic vector (Promega). Enhancer
fragments were subsequently cloned into the BamHI and SalI sites of the
pGL3-pOct4 vector. The v6.5 murine ESCs were transfected using Lipofect-
amine 2000 (Invitrogen). The pRL-SV40 plasmid (Promega) was cotransfected
as a normalization control. Cells were incubated for 24 hr, and luciferase activ-
ity was measured using the Dual-Luciferase Reporter Assay System (Prom-
ega). The genomic coordinates of the cloned fragments are found in Table S7.
Data Analysis
All ChIP-seq data sets were aligned using Bowtie (version 0.12.2) (Langmead
et al., 2009) to build version MM9 of the mouse genome. Data sets used in this
manuscript can be found in Table S8.
We developed a simplemethod to calculate the normalized read density of a
ChIP-seq data set in any region. ChIP-seq reads aligning to the region were
extended by 200 base pairs, and the density of reads per base pair (bp) was
calculated. The density of reads in each region was normalized to the total
number of million mapped reads producing read density in units of reads
per million mapped reads per base pair (rpm/bp).
We used the MACS version 1.4.1 (model-based analysis of ChIP-seq)
(Zhang et al., 2008) peak finding algorithm to identify regions of ChIP-seq
enrichment over background. A p value threshold of enrichment of 109 was
used for all data sets.
Enhancers were defined as regions of ChIP-seq enrichment for transcription
factor(s). In order to accurately capture dense clusters of enhancers, we
allowed regions within 12.5 kb of one another to be stitched together.
The methods for identifying and characterizing super-enhancers, as well as
assignment of enhancers to genes, are fully described in the Extended Exper-
imental Procedures.
ACCESSION NUMBERS
The GEO accession ID for aligned and raw data is GSE44288 (www.ncbi.nlm.
nih.gov/geo/).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, one data file, and eight tables and can be found with this article online
at http://dx.doi.org/10.1016/j.cell.2013.03.035.
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